Diligence memo · auto-generated · as of July 2, 2026

Blue Summit Hospice & Palliative Care, Inc.

Blue Summit Hospice & Palliative Care, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Blue Summit Hospice & Palliative Care, Inc. operates in Healthtech, based in ATLANTA.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Blue Summit Hospice & Palliative Care, Inc. has raised $170K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $170K on 2022-08-29.

Most recent recorded round closed around 2022-08-29.

Valuation (modeled)modeled

Provath models Blue Summit Hospice & Palliative Care, Inc. at approximately $1.9M (range $107K–$11M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.69× the median modeled value of Pre-Seed Healthtech companies in 2022–2024 (174 peers) — value vs value, same stage and era. Within the normal band (69% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 3.8 yr ago; this sector typically re-raises about every 14 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 12% of Healthtech peers (2138 compared).

Modeled value ranks above 15% of those peers.

Closest niche peers: Hoy Health Corp, Ennova Health LLC, Telebelly Health, Inc., Health Rosetta Group PBC, B2M Medical, Inc..

Peoplefiled

1 named person on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.